malondialdehyde has been researched along with febuxostat in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Shafik, AN | 1 |
| Fahmi, AN; Salem, HA; Shebl, AM; Shehatou, GS | 2 |
| Abd El-Raouf, OM; Gad, AM; Khalaf, MM; Khames, A | 1 |
| Amirshahrokhi, K | 1 |
| Abu-Risha, SE; Amer, MS; El-Mahdy, NA; Saleh, DA | 1 |
| Bando, YK; Fujii, Y; Kadokami, T; Koide, H; Murohara, T; Node, K; Nomura, S; Saito, M; Sano, H; Tanaka, A; Teragawa, H; Ueda, T; Yoshida, H | 1 |
1 trial(s) available for malondialdehyde and febuxostat
| Article | Year |
|---|---|
Effect of febuxostat on the level of malondialdehyde-modified low-density lipoprotein, an oxidative stress marker: A subanalysis of the PRIZE study.
Topics: Carotid Artery Diseases; Cholesterol, LDL; Febuxostat; Humans; Hyperuricemia; Malondialdehyde; Oxidative Stress; Uric Acid | 2023 |
6 other study(ies) available for malondialdehyde and febuxostat
| Article | Year |
|---|---|
Febuxostat improves the local and remote organ changes induced by intestinal ischemia/reperfusion in rats.
Topics: Alanine Transaminase; Allopurinol; Animals; Aspartate Aminotransferases; Dose-Response Relationship, Drug; Febuxostat; Gout Suppressants; Intestinal Mucosa; Lipid Peroxidation; Lung; Male; Malondialdehyde; Muscle Contraction; Muscle, Smooth; Peroxidase; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Thiazoles; Tumor Necrosis Factor-alpha; Xanthine Dehydrogenase; Xanthine Oxidase | 2013 |
Febuxostat protects rats against lipopolysaccharide-induced lung inflammation in a dose-dependent manner.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; C-Reactive Protein; Dose-Response Relationship, Drug; Febuxostat; Glutathione; L-Lactate Dehydrogenase; Leukocyte Count; Lipopolysaccharides; Lung; Male; Malondialdehyde; Nitric Oxide; Pulmonary Edema; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Xanthine Oxidase | 2016 |
Febuxostat exerts dose-dependent renoprotection in rats with cisplatin-induced acute renal injury.
Topics: Acute Kidney Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Cisplatin; Creatinine; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Febuxostat; Glutathione; Inflammation Mediators; Kidney; L-Lactate Dehydrogenase; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Proteinuria; Rats, Sprague-Dawley; Serum Albumin; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Urological Agents; Xanthine Oxidase | 2016 |
Ameliorative effects of sildenafil and/or febuxostat on doxorubicin-induced nephrotoxicity in rats.
Topics: Animals; Apoptosis; Caspase 3; Creatinine; Cytoprotection; Doxorubicin; Drug Interactions; Febuxostat; Gene Expression Regulation, Enzymologic; Glutathione; Kidney; Male; Malondialdehyde; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sildenafil Citrate; Tumor Necrosis Factor-alpha; Urea; Uric Acid | 2017 |
Febuxostat attenuates ulcerative colitis by the inhibition of NF-κB, proinflammatory cytokines, and oxidative stress in mice.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents; Antioxidants; Colitis, Ulcerative; Colon; Cytokines; Febuxostat; Glutathione; Male; Malondialdehyde; Mice, Inbred BALB C; NF-kappa B; Nitric Oxide; Oxidative Stress; Peroxidase; Superoxide Dismutase; Xanthine Oxidase | 2019 |
Role of allopurinol and febuxostat in the amelioration of dextran-induced colitis in rats.
Topics: Allopurinol; Animals; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Dextran Sulfate; Drug Therapy, Combination; Febuxostat; Glutathione; Interleukin-1beta; Interleukin-6; Male; Malondialdehyde; Rats, Wistar; Sulfasalazine; Superoxide Dismutase; Uric Acid; Xanthine Oxidase | 2020 |